24208-911Level 3
Xiidra (Lifitegrast)
**Product type:** Human Prescription Drug
**Active ingredient:** LIFITEGRAST
**Strength:** 50 mg/mL
**Dosage form:** Solution/ Drops
**Route:** Ophthalmic
**Labeler:** Bausch & Lomb Incorporated
**Marketing category:** NDA (NDA208073)
**Pharmacologic class:** Lymphocyte Function-Associated Antigen-1 Antagonist [EPC], Lymphocyte Function-Associated Antigen-1 Antagonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/24208-911Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.